Status:
RECRUITING
Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants
Lead Sponsor:
Euroteknika
Collaborating Sponsors:
EVAMED
Conditions:
Edentulous Mouth
Eligibility:
All Genders
18+ years
Brief Summary
Real-life evaluation of the safety and performance of EUROTEKNIKA dental implants
Detailed Description
Many adults have one or more missing teeth. The negative consequences of partial or total edentulousness are numerous at the level of the orofacial sphere : * Edentulism generates a strong aesthetic ...
Eligibility Criteria
Inclusion
- Patient aged 18 or over
- Patient who has completed bone growth
- Patient informed and agreeing to participate in the study
- Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort)
- Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort)
- Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort)
- Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort)
Exclusion
- Pregnant or breastfeeding women (for the prospective cohort)
- Patient with bone disease in the cervico-facial region
- Patient refusing to participate in the study
- Patient with at least one contraindication to implantation (for the prospective cohort)
- Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort)
- Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort)
- Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort)
- Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort)
Key Trial Info
Start Date :
March 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2028
Estimated Enrollment :
868 Patients enrolled
Trial Details
Trial ID
NCT05375045
Start Date
March 25 2022
End Date
February 1 2028
Last Update
May 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Clermont Ferrand
Clermont-Ferrand, France, 63003